Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.


  • Molecular trigger for cerebral cavernous malformation identified

  • Even the elderly can recover from a severe traumatic brain injury

  • White matter damage caused by 'skunk-like' cannabis, study shows

  • Lower availability of omega-3 fatty acids in the body associated with bipolar disorder

  • New protein biomarker identifies damaged brain wiring after concussion

  • Loneliness triggers cellular changes that can cause illness, study shows

  • How cocaine changes the brain

  • Neuroscientists gain insight into cause of Alzheimer's symptoms

  • Food odors activate impulse area of the brain in obese children

  • Immune-disorder treatment in mice holds potential for multiple sclerosis patients